Katharos, Inc.

PHOSFILTER selective phosphate adsorption improves the health of dialysis patients and lowers the cost of hyperphosphatemia healthcare.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Raleigh, NC, USA
  • Currency USD
  • Founded August 2009
  • Employees 2

Company Summary

Katharos is commercializing the PHOSFILTER, a medical device for selective blood phosphate adsorption that will improve hemodialysis patient quality of life, reduced mortality and lower the cost of healthcare associated with hyperphosphatemia. This device will reduce requirements for oral phosphate binding pills and its related limitations and side effects.

Team

  • Albert D Bender
    CEO

    Dr. Bender, a successful serial entrepreneur, has provided the strategic vision and leadership for 4 high-tech companies that achieved technical leadership and growth to enable their sale at a good return for the VC and angel investors. During his career, Dr. Bender has raised 10 rounds of venture capital totaling more than $150M. He has proven successes in: business strategy; operations; technology; sales and marketing; and raising capital.

  • Bruce J Oberhardt
    Chief Scientific Officer

    Dr. Oberhardt has led and/or participated in a number of first-of-a-kind technological developments including “CoaguChek” and founded Cardiovascular Diagnostics: a successful IPO. The “CoaguChek” is a medical device that provides a systematic approach to anticoagulation management, focused at the point of care.

  • Marian G. McCord
    Founder/Scientific Advisor

    Dr. McCord is an Associate Professor with appointments in the Department of Textile Engineering, Chemistry, and Science at NCSU, Raleigh, the Joint UNC/NCSU Department of Biomedical Engineering, and an Adjunct Associate Professor of Medicine at UNC. She has 15 years of experience in development and characterization of medical textiles, and has been active in consulting for the medical device industry

  • Melanie S. Joy
    Founder/Scientific Advisor

    Dr. Joy is an accomplished translational researcher having spent the last 20 years as a researcher and clinician in nephrology, pharmacology, and pharmaceutics. Dr. Joy spent the last 16 years at UNC where she was an Associate Professor of Nephrology and Pharmacy. She currently maintains an Adjunct position with the UNC Kidney Center. She recently relocated to the University of Colorado to accept a faculty position in Nephrology.

Advisors

  • Merrill Mason; Smith Anderson
    Lawyer
    Unconfirmed
    NA
    Accountant
    Unconfirmed

Previous Investors

  • No Katharos Investors
    Unconfirmed
    Product development has been funded by a $245K Coulter Grant
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free